| Q47595039 | A Raf-induced, MEK-independent signaling pathway regulates atrial natriuretic factor gene expression in cardiac muscle cells |
| Q39444769 | A low-affinity serum response element allows other transcription factors to activate inducible gene expression in cardiac myocytes |
| Q54634475 | Activation of mitogen activated protein kinases in post-infarcted patients |
| Q33883079 | Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists |
| Q44036971 | Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. |
| Q34164033 | Adenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy |
| Q34465695 | Adrenergic regulation of cardiac myocyte apoptosis |
| Q37328603 | An endogenously produced fragment of cardiac myosin-binding protein C is pathogenic and can lead to heart failure |
| Q43640260 | Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes |
| Q46479908 | Bigendothelin-1 (1-21) fragment during early sepsis modulates tau, p38-MAPK phosphorylation and nitric oxide synthase activation |
| Q35230062 | CB2 cannabinoid receptor targets mitogenic Gi protein–cyclin D1 axis in osteoblasts |
| Q40816391 | Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes. |
| Q36660414 | Calcium signaling phenomena in heart diseases: a perspective |
| Q36760711 | Can the cardiomyocyte cell cycle be reprogrammed? |
| Q33665828 | Cardiac hypertrophy: sorting out the circuitry |
| Q40051060 | Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis |
| Q41045444 | Cardiogenic Shock and Respiratory Failure in a Patient With Metastatic Melanoma Receiving Trametinib Therapy |
| Q37165488 | Cardiotoxicity profile of trastuzumab |
| Q46007992 | Caveolin-1 restoration by cholesterol enhances the inhibitory effect of simvastatin on arginine vasopressin-induced cardiac fibroblasts proliferation. |
| Q37634351 | Characterization of a novel MK3 splice variant from murine ventricular myocardium |
| Q36544841 | Characterization of hsp27 kinases activated by elevated aortic pressure in heart. |
| Q39730292 | Characterization of the expression and regulation of MK5 in the murine ventricular myocardium |
| Q38088974 | Chemotherapy-related cardiotoxicity |
| Q48021797 | Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways. |
| Q78081337 | Differential effects of 17beta-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes |
| Q28584249 | Differential regulation of Krüppel-like factor family transcription factor expression in neonatal rat cardiac myocytes: effects of endothelin-1, oxidative stress and cytokines |
| Q46252131 | Differential roles of MAPKs and MSK1 signalling pathways in the regulation of c-Jun during phenylephrine-induced cardiac myocyte hypertrophy |
| Q36002854 | Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction |
| Q28583675 | Distinct roles of mitogen-activated protein kinase pathways in GATA-4 transcription factor-mediated regulation of B-type natriuretic peptide gene |
| Q24804200 | Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction |
| Q33549651 | ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes |
| Q44739752 | Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts |
| Q47928468 | Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion |
| Q41031513 | Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors |
| Q74191149 | Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development |
| Q46895528 | Estrogen receptor-alpha mediates acute myocardial protection in females |
| Q41919050 | Feedback regulation by Atf3 in the endothelin-1-responsive transcriptome of cardiomyocytes: Egr1 is a principal Atf3 target |
| Q24555199 | Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy |
| Q28301647 | Focal adhesion kinase is essential for costamerogenesis in cultured skeletal muscle cells |
| Q34418959 | G protein-coupled receptor signalling in in vivo cardiac overload |
| Q35109612 | Garlic Oil Alleviates MAPKs- and IL-6-mediated Diabetes-related Cardiac Hypertrophy in STZ-induced DM Rats |
| Q43601486 | Gastrin-induced DNA synthesis requires p38-MAPK activation via PKC/Ca(2+) and Src-dependent mechanisms |
| Q35956966 | Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo |
| Q79826698 | Global changes in gene expression during cardiac hypertrophy: a new direction of cardiac signaling research |
| Q36497030 | Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis |
| Q92980782 | Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies |
| Q43819526 | High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor |
| Q44939590 | Immunolocalization of type 2 inositol 1,4,5-trisphosphate receptors in cardiac myocytes from newborn mice |
| Q24806335 | Inability of serotonin to activate the c-Jun N-terminal kinase and p38 kinase pathways in rat aortic vascular smooth muscle cells |
| Q46824205 | Inhibition of angiotensin II- and endothelin-1-stimulated proliferation by selective MEK inhibitor in cultured rabbit gingival fibroblastsdagger. |
| Q41730133 | Integrin dependence of brain natriuretic peptide gene promoter activation by mechanical strain |
| Q33959657 | Ischemic preconditioning: from basic mechanisms to clinical applications |
| Q35058555 | Kinases as therapeutic targets for heart failure |
| Q81044990 | Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells |
| Q43852680 | Load-induced focal adhesion kinase activation in the myocardium: role of stretch and contractile activity |
| Q40645647 | Lysophosphatidic acid stimulates CREB through mitogen- and stress-activated protein kinase-1. |
| Q34627221 | MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation |
| Q36481935 | MK2 Regulates Ras Oncogenesis through Stimulating ROS Production |
| Q33902374 | Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism |
| Q44591495 | Metalloendopeptidase Inhibition Regulates Phosphorylation of p38???Mitogen-Activated Protein Kinase and Nitric Oxide Synthase in Heart After Endotoxemia |
| Q35169365 | Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology |
| Q46923162 | Multiple signaling pathways are involved in endothelin-1-induced brain endothelial cell migration |
| Q40851060 | Myocyte hypertrophy: the long and winding RhoA'd |
| Q28343899 | Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors |
| Q35679460 | Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease |
| Q51736896 | Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats. |
| Q44771526 | PKC-epsilon regulation of extracellular signal-regulated kinase: a potential role in phenylephrine-induced cardiocyte growth |
| Q40812567 | Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade |
| Q24534309 | Phosphorylation and activation of mitogen- and stress-activated protein kinase-1 in adult rat cardiac myocytes by G-protein-coupled receptor agonists requires both extracellular-signal-regulated kinase and p38 mitogen-activated protein kinase |
| Q33707676 | Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. |
| Q48713598 | Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. |
| Q37664269 | Profilin-1 promotes the development of hypertension-induced artery remodeling |
| Q33897027 | Rapid activation of G2/M checkpoint after hypertonic stress in renal inner medullary epithelial (IME) cells is protective and requires p38 kinase |
| Q43508628 | Ras regulates NFAT3 activity in cardiac myocytes |
| Q34920635 | Receptor crosstalk. Implications for cardiovascular function, disease and therapy |
| Q34276846 | Regulation of E2F1-dependent gene transcription and apoptosis by the ETS-related transcription factor GABPgamma1. |
| Q44348326 | Regulation of MAPK pathways in response to purinergic stimulation of adult rat cardiac myocytes |
| Q58001211 | Regulation of Ras·GTP Loading and Ras-Raf Association in Neonatal Rat Ventricular Myocytes by G Protein-coupled Receptor Agonists and Phorbol Ester |
| Q35609851 | Regulation of blood pressure and salt homeostasis by endothelin |
| Q33857393 | Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases |
| Q43625181 | Regulation of cardiac myocyte protein synthesis through phosphatidylinositol 3' kinase and protein kinase B. |
| Q34467657 | Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. |
| Q28346098 | Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1 |
| Q37284634 | Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure |
| Q24682791 | Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases |
| Q36798390 | Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses |
| Q52723296 | Size uniformity of animal cells is actively maintained by a p38 MAPK-dependent regulation of G1-length. |
| Q28344062 | Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro |
| Q31956016 | Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway |
| Q46875217 | Subdepressor dose of benidipine ameliorates diabetic cardiac remodeling accompanied by normalization of upregulated endothelin system in rats |
| Q41875026 | Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes |
| Q34187021 | TAO (thousand-and-one amino acid) protein kinases mediate signaling from carbachol to p38 mitogen-activated protein kinase and ternary complex factors. |
| Q28343890 | Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy |
| Q39752687 | Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling |
| Q40388321 | The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice |
| Q61912834 | The Multiple Actions of the Insulin-Like Growth Factor-I Signaling in the Myocardium |
| Q28348605 | The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression. |
| Q36597976 | The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation |
| Q33838890 | The role of p38alpha mitogen-activated protein kinase gene in the HELLP syndrome |
| Q24548283 | The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes |
| Q38294814 | The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade |
| Q28362213 | Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA |
| Q42469415 | Transcriptional activation of the glucose transporter GLUT1 in ventricular cardiac myocytes by hypertrophic agonists |
| Q37255343 | Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1 |
| Q43002384 | Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein |
| Q53619418 | Using U0126 to dissect the role of the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes. |
| Q40633146 | Viral Induction of Inflammatory Cytokines in Human Epithelial Cells Follows a p38 Mitogen-Activated Protein Kinase-Dependent but NF-κB-Independent Pathway |
| Q37101602 | With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure |
| Q41736665 | alpha B-crystallin gene induction and phosphorylation by MKK6-activated p38. A potential role for alpha B-crystallin as a target of the p38 branch of the cardiac stress response |
| Q40778028 | p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response |
| Q44185266 | p38 mitogen-activated protein kinase inhibits calcium-dependent chloride secretion in T84 colonic epithelial cells. |
| Q34372422 | p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. |
| Q36776721 | α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion |